Nelfinavir

Last Updated: 11/08/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1953 publications

Nelfinavir Synergizes with Cisplatin and Promotes GSDME-Associated Lytic Cell Death in Platinum-Resistant Ovarian Cancer Cells.

Nelfinavir Synergizes with Cisplatin and Promotes GSDME-Associated Lytic Cell Death in Platinum-Resistant Ovarian Cancer Cells.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: September 24, 2026

Metabolic Targeting of SREBP1 Reprograms the Obesity-Driven Ascites Immune Microenvironment and Enhances Chemotherapy Response in Obesity-Associated Ovarian Cancer.

Metabolic Targeting of SREBP1 Reprograms the Obesity-Driven Ascites Immune Microenvironment and Enhances Chemotherapy Response in Obesity-Associated Ovarian Cancer.

Journal: bioRxiv : the preprint server for biology

Published: September 24, 2026

Drug repurposing identifies candidate uterus-selective tocolytics for preterm labor.

Drug repurposing identifies candidate uterus-selective tocolytics for preterm labor.

Journal: Science translational medicine

Published: September 23, 2026

Enhanced NRF1-mediated proteasome bounce-back and nelfinavir-mediated bortezomib sensitization in gemcitabine/cisplatin-resistant bladder cancer cells.

Enhanced NRF1-mediated proteasome bounce-back and nelfinavir-mediated bortezomib sensitization in gemcitabine/cisplatin-resistant bladder cancer cells.

Journal: Biochemical and biophysical research communications

Published: September 20, 2026

Integrative transcriptomic and molecular dynamics simulations analysis identifies IL6 as a therapeutic hub gene in inflammatory arthritis.

Integrative transcriptomic and molecular dynamics simulations analysis identifies IL6 as a therapeutic hub gene in inflammatory arthritis.

Journal: Computational biology and chemistry

Published: June 14, 2026

Upamostat potentiates bortezomib cytotoxicity and delays proteasome recovery in bortezomib-resistant malignant lymphoma cells through modulation of the DDI2/NRF1 axis.

Upamostat potentiates bortezomib cytotoxicity and delays proteasome recovery in bortezomib-resistant malignant lymphoma cells through modulation of the DDI2/NRF1 axis.

Journal: Biochimica et biophysica acta. Molecular cell research

Published: May 24, 2026

Non-Canonical Binding of Nelfinavir in HIV-1 Protease Variants Reveals Structural Mechanisms of Antiretroviral Resistance.

Non-Canonical Binding of Nelfinavir in HIV-1 Protease Variants Reveals Structural Mechanisms of Antiretroviral Resistance.

Journal: Viruses

Published: May 22, 2026

An efficient and versatile reverse genetics system for bovine coronavirus facilitates antiviral evaluation.

An efficient and versatile reverse genetics system for bovine coronavirus facilitates antiviral evaluation.

Journal: Veterinary research

Published: May 08, 2026

A combination of MD-derived pharmacophores and structure-based strategy identifies dual allosteric inhibitors of NS2B-NS3 proteases in Zika and West Nile viruses.

A combination of MD-derived pharmacophores and structure-based strategy identifies dual allosteric inhibitors of NS2B-NS3 proteases in Zika and West Nile viruses.

Journal: European journal of medicinal chemistry

Published: April 21, 2026

HIV-1 cell-to-cell infection of macrophages escapes restriction by the BST-2 host cell factor independently of the Vpu counteracting viral protein.

HIV-1 cell-to-cell infection of macrophages escapes restriction by the BST-2 host cell factor independently of the Vpu counteracting viral protein.

Journal: PLoS pathogens

Published: April 09, 2026

Causal association and molecular mechanisms of periodontal disease and muscle wasting and atrophy: Mendelian randomization and bioinformatics analysis.

Causal association and molecular mechanisms of periodontal disease and muscle wasting and atrophy: Mendelian randomization and bioinformatics analysis.

Journal: Frontiers in genetics

Published: February 12, 2026

A Priori Design, Combinatorial Synthesis, and Assessment of an Antipackaging Peptide Against Human Immunodeficiency Virus 1: Functional Role of Unnatural Trp Mimetics and Serendipitous Discovery of a Protease Inhibitor.

A Priori Design, Combinatorial Synthesis, and Assessment of an Antipackaging Peptide Against Human Immunodeficiency Virus 1: Functional Role of Unnatural Trp Mimetics and Serendipitous Discovery of a Protease Inhibitor.

Journal: ChemMedChem

Published: December 09, 2025

Showing 1-12 of 1,953

Last Updated: 11/08/2026